General Information of DTT (ID: TTRPDBG)

DTT Name Inhibitor of nuclear factor kappa-B kinase (IKK) DTT Info
Gene Name IKK

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
Investigative Drug(s)
4 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dihydrothieno [2,3-e]indazole derivative 1 DMUJ3XK N. A. N. A. Patented [1]
Dihydrothieno [2,3-e]indazole derivative 2 DM0D3HU N. A. N. A. Patented [1]
Dihydrothieno [2,3-e]indazole derivative 3 DM85VQR N. A. N. A. Patented [1]
Dihydrothieno [2,3-e]indazole derivative 4 DMR4LPO N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
10 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
4-hydroxy-2-nonenal DM2LJFZ Discovery agent N.A. Investigative [2]
5-Bromo-6-methoxy-9H-beta-carboline DM157OQ Discovery agent N.A. Investigative [3]
Arsenite DMBCO4Q Discovery agent N.A. Investigative [4]
BMS-345541 DM7D519 Arthritis FA20 Investigative [5]
MLN-120B DMYKNSP Discovery agent N.A. Investigative [6]
MRT67307 DMYRCHG Discovery agent N.A. Investigative [7]
PMID23099093C17d DMWS7O9 Discovery agent N.A. Investigative [8]
PS-1145 DMVUMWZ Multiple myeloma 2A83 Investigative [9]
S1627 DMD4KLQ Discovery agent N.A. Investigative [10]
TPCA-1 DMA14PR Discovery agent N.A. Investigative [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Novel NF-B inhibitors: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):319-34.
2 IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem. 2001 May 25;276(21):18223-8.
3 Novel IKK inhibitors: beta-carbolines. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2419-22.
4 Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem. 2000 Nov 17;275(46):36062-6.
5 A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 2003 Sep;48(9):2652-9.
6 A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like syno... J Pharmacol Exp Ther. 2006 Jun;317(3):989-1001.
7 Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2011 Feb 15;434(1):93-104.
8 Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKepsilon kinases. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7169-73.
9 Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127.
10 Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 2004 Feb 18;24(7):1637-45.
11 Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbo... J Pharmacol Exp Ther. 2005 Jan;312(1):373-81.